INSIDERFilingvia Quantisnow
Nu Skin Enterprises Inc. logo

Nu Skin Enterprises (NUS) director Zorko received 26,643 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Mark A Zorko (director at Nu Skin Enterprises Inc., NUS) reported that they received 26,643 shares on Jun 1, 2026. After these transactions the filing shows 60,586 shares held directly.

Reporting person
Zorko Mark A
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 1, 2026Grant or award (A)Class A Common Stock+26,643--60,586 direct

Holdings before and after

  • Class A Common Stock: 33,943 to 60,586 direct

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Zorko report in this NUS Form 4?

Mark A Zorko (director at Nu Skin Enterprises Inc., NUS) reported that they received 26,643 shares on Jun 1, 2026. After these transactions the filing shows 60,586 shares held directly.

How many NUS shares does Zorko hold after this filing?

The filing shows 60,586 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for NUS

Across the 10 sessions after earlier NUS headlines, the stock closed higher 7 times and lower 3 times, with a median move of 2.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

NUS close-to-close change in the session after earlier headlines
SessionEarlier headlineNUSSPY
May 8, 2026Nu Skin Enterprises Reports First Quarter Resultsand 1 other headline that session+2.0%+0.8%
Apr 14, 2026Nu Skin Enterprises to Announce First Quarter 2026 Financial Results+3.1%+1.2%
Apr 6, 2026Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness+1.5%+0.5%
Mar 23, 2026Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer+1.0%+1.1%
Mar 10, 2026Nu Skin Appoints Chayce Clark as COO-1.2%-0.2%
Feb 13, 2026Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidanceand 1 other headline that session-18.1%+0.1%

Earlier insider filings at NUS

Keep researching NUS

Quantisnow market dataNYSE
Nu Skin Enterprises Inc. logo
NUS
Nu Skin Enterprises Inc.
Market cap
30-day
Sector
Health Care
Industry
Other Pharmaceuticals
Listed since
1996
Get push alerts for NUS

Follow NUS and get a push notification the moment its next story breaks.

Full NUS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NUS (Nu Skin Enterprises Inc.) and more on Quantisnow.